{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:12:19Z","timestamp":1762506739901},"reference-count":26,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"12","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:title>Abstract:<\/jats:title>\n          <jats:p>Treatment with interferon (IFN) could be associated with variable cutaneous adverse reactions. The aim of this study was to describe the clinicopathological spectrum of cutaneous granulomas associated with IFN therapy and identify the causal relation between IFN therapy and granulomatous reactions. The study included 18 patients (16 males and 2 females) with an average age of 48 years. Clinically, most of the lesions were solitary (83.3%) and located on the face (44.4%) and\/or trunk (38.9%). The lesions were commonly presented as nodules (33.3%) or plaques (27.8%) with a common size of 5\u201310 cm. Granulomatous reactions were localized to the injection site in 4 cases, distributed on other body areas (remote granuloma) in 11 cases, and associated with lung involvement (systemic granuloma) in 3 cases. Histologically, injection site granuloma showed suppurative reaction in 75% and sarcoidal reaction in 25%. Remote granuloma showed tuberculoid reaction in 27.3%, interstitial in 27.3%, and sarcoidal in 45.4%. Systemic granuloma showed sarcoidal reaction in all cases. After withdrawal of IFN, only 3 lesions showed spontaneous complete clearance, whereas most of the lesions (83.3%) showed only partial improvement. Our results suggested that IFN is not a causal agent of all associated cutaneous granulomas but it mostly provokes the appearance of granulomatous reactions in susceptible individuals. Findings that prove this concept include the formation of granuloma in body sites away from the injection site, the heterogeneous pattern of granuloma both clinically and histologically, and incomplete clearance of most of the lesions after withdrawal of IFN.<\/jats:p>","DOI":"10.1097\/dad.0000000000000547","type":"journal-article","created":{"date-parts":[[2016,2,24]],"date-time":"2016-02-24T11:05:56Z","timestamp":1456311956000},"page":"892-899","source":"Crossref","is-referenced-by-count":7,"title":["Cutaneous Granulomas Associated With Interferon Therapy"],"prefix":"10.1097","volume":"38","author":[{"given":"Mohamed","family":"El-Khalawany","sequence":"first","affiliation":[{"name":"Department of Dermatology, Al-Azhar University, Cairo, Egypt;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Inass","family":"Mohammad","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Al-Azhar University for girls, Cairo, Egypt;"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soha","family":"Aboeldahab","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Sohag University, Sohag, Egypt; and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aida","family":"Thabet","sequence":"additional","affiliation":[{"name":"Department of Dermatology, Sohag University, Sohag, Egypt; and"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230908","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1517\/14740330802423291","article-title":"Safety of peginterferon in the treatment of chronic hepatitis C","volume":"7","author":"Hashemi","year":"2008","journal-title":"Expert Opin Drug Saf."},{"key":"R2-20230908","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S0168-8278(96)80184-X","article-title":"A survey of adverse events in 11,241 patients with chronic viral hepatitis treated with alfa interferon","volume":"24","author":"Fattovich","year":"1996","journal-title":"J Hepatol."},{"key":"R3-20230908","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/00042737-199811000-00006","article-title":"A prospective evaluation of dermatological side-effects during alpha-interferon therapy for chronic viral hepatitis","volume":"10","author":"Dalekos","year":"1998","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"R4-20230908","first-page":"591","article-title":"Pegylated interferon associated lichen planus at the injection site","volume":"74","author":"Erg\u00fcl","year":"2011","journal-title":"Acta Gastroenterol Belg."},{"key":"R5-20230908","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2310\/7750.2013.13051","article-title":"Erythema annulare centrifugum due to pegylated interferon-\u03b1-2a plus ribavirin combination therapy in a patient with chronic hepatitis C virus infection","volume":"18","author":"G\u00f6n\u00fcl","year":"2014","journal-title":"J Cutan Med Surg."},{"key":"R6-20230908","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.jfma.2014.07.008","article-title":"Sarcoidosis on the injection sites following treatment of interferon-alpha and ribavirin for hepatitis C","volume":"113","author":"Chiang","year":"2014","journal-title":"J Formos Med Assoc."},{"key":"R7-20230908","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1159\/000095048","article-title":"Generalized interstitial granuloma annulare induced by pegylated interferon-alpha","volume":"213","author":"Kluger","year":"2006","journal-title":"Dermatology"},{"key":"R8-20230908","first-page":"432","article-title":"Development of sarcoidosis during interferon alpha 2b and ribavirin combination therapy for chronic hepatitis C\u2013a case report and review of the literature","volume":"68","author":"Bolukbas","year":"2005","journal-title":"Acta Gastroenterol Belg."},{"key":"R9-20230908","doi-asserted-by":"crossref","first-page":"2994","DOI":"10.1128\/jcm.33.11.2994-2998.1995","article-title":"Detection and identification of mycobacteria by DNA amplification and oligonucleotide-specific capture plate hybridization","volume":"33","author":"De Beenhouwer","year":"1995","journal-title":"J Clin Microbiol."},{"key":"R10-20230908","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/29.4.6166661","article-title":"Use of avidin-biotin-peroxidase complex (ABC) in immunoperoxidase techniques: a comparison between ABC and unlabeled antibody (PAP) procedures","volume":"29","author":"Hsu","year":"1981","journal-title":"J Histochem Cytochem."},{"key":"R11-20230908","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1186\/1743-422X-8-466","article-title":"Determination of HCV genotypes and viral loads in chronic HCV infected patients of hazara Pakistan","volume":"8","author":"Ali","year":"2011","journal-title":"Virol J."},{"key":"R12-20230908","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/01.md.0000157577.69729.e6","article-title":"Sarcoidosis in patients with chronic hepatitis C virus infection: analysis of 68 cases","volume":"84","author":"Ramos-Casals","year":"2005","journal-title":"Medicine"},{"key":"R13-20230908","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.jaad.2003.06.013","article-title":"Cutaneous sarcoidosis associated with pegylated interferon alfa and ribavirin therapy in a patient with chronic hepatitis C","volume":"50","author":"Rogers","year":"2004","journal-title":"J Am Acad Dermatol."},{"key":"R14-20230908","first-page":"149","article-title":"ATS\/ERS\/WASOG statement on sarcoidosis. American Thoracic Society\/European Respiratory Society\/World association of sarcoidosis and other granulomatous disorders","volume":"16","author":"Hunninghake","year":"1999","journal-title":"Sarcoidosis Vasc Diffuse Lung Dis."},{"key":"R15-20230908","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.4049\/jimmunol.161.4.2011","article-title":"IFN-alpha priming of human monocytes differentially regulates gram-positive and gram-negative bacteria-induced IL-10 release and selectively enhances IL-12p70, CD80, and MHC class I expression","volume":"161","author":"Hermann","year":"1998","journal-title":"J Immunol."},{"key":"R16-20230908","first-page":"1","article-title":"Interferon-induced sarcoidosis","volume":"19","author":"Cardoso","year":"2011","journal-title":"BMJ Case Rep."},{"key":"R17-20230908","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1111\/j.1742-1241.2005.00651.x","article-title":"Interferon-induced sarcoidosis","volume":"60","author":"Alazemi","year":"2006","journal-title":"Int J Clin Pract."},{"key":"R18-20230908","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1159\/000029581","article-title":"The prevalence of serum antibodies to hepatitis C virus is not increased in patients with sarcoidosis","volume":"67","author":"Mert","year":"2000","journal-title":"Respiration"},{"key":"R19-20230908","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1529-8019.2009.01263.x","article-title":"Cutaneous lesions as initial signs of interferon alpha-induced sarcoidosis: report of three new cases and review of the literature","volume":"22","author":"Fantini","year":"2009","journal-title":"Dermatol Ther."},{"key":"R20-20230908","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1097\/MJT.0b013e318209e049","article-title":"Hepatitis C virus treatment with pegylated interferon-alfa therapy leading to generalized interstitial granuloma annulare and review of the literature","volume":"20","author":"Ahmad","year":"2013","journal-title":"Am J Ther."},{"key":"R21-20230908","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-0560.1998.tb01693.x","article-title":"The interstitial granulomatous drug reaction: a distinctive clinical and pathological entity","volume":"25","author":"Magro","year":"1998","journal-title":"J Cutan Pathol."},{"key":"R22-20230908","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/DAD.0b013e3181c0e14d","article-title":"Allopurinol-induced DRESS syndrome with a histologic pattern consistent with interstitial granulomatous drug reaction","volume":"36","author":"Kim","year":"2014","journal-title":"Am J Dermatopathol."},{"key":"R23-20230908","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1097\/00000372-200108000-00003","article-title":"Interstitial granulomatous drug reaction with a histological pattern of interstitial granulomatous dermatitis","volume":"23","author":"Perrin","year":"2001","journal-title":"Am J Dermatopathol."},{"key":"R24-20230908","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1590\/abd1806-4841.20131986","article-title":"Borderline tuberculoid leprosy and type 1 leprosy reaction in a hepatitis C patient during treatment with interferon and ribavirin","volume":"88","author":"Santos","year":"2013","journal-title":"An Bras Dermatol."},{"key":"R25-20230908","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.jinf.2006.12.009","article-title":"Interferon-alpha treatment of hepatitis D induces tuberculosis exacerbation in an immigrant","volume":"54","author":"Telesca","year":"2007","journal-title":"J Infect."},{"key":"R26-20230908","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1080\/00365540500263268","article-title":"Reactivation of severe, acute pulmonary tuberculosis during treatment with pegylated interferon-alpha and ribavirin for chronic HCV hepatitis","volume":"38","author":"Sabbatani","year":"2006","journal-title":"Scand J Infect Dis."}],"container-title":["The American Journal of Dermatopathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00000372-201612000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T05:06:28Z","timestamp":1694149588000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00000372-201612000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":26,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/dad.0000000000000547","relation":{},"ISSN":["0193-1091"],"issn-type":[{"value":"0193-1091","type":"print"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}